5-Chloro-2-methoxybenzene-1-sulfonyl chloride → HCID 67365348, compound

HRID 524228Notes

Reaction equation

HRID 524228 reaction equation
Cl.[CH3:2][O:3][C:4]1[CH:5]=[C:6]([C:12]2[C:13]([CH3:25])([CH3:24])[C:14](=[O:23])[N:15]([CH:17]3[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]3)[N:16]=2)[CH:7]=[CH:8][C:9]=1[O:10][CH3:11].[Cl:26][C:27]1[CH:28]=[CH:29][C:30]([O:37][CH3:38])=[C:31]([S:33](Cl)(=[O:35])=[O:34])[CH:32]=1>>[Cl:26][C:27]1[CH:28]=[CH:29][C:30]([O:37][CH3:38])=[C:31]([S:33]([N:20]2[CH2:21][CH2:22][CH:17]([N:15]3[C:14](=[O:23])[C:13]([CH3:25])([CH3:24])[C:12]([C:6]4[CH:7]=[CH:8][C:9]([O:10][CH3:11])=[C:4]([O:3][CH3:2])[CH:5]=4)=[N:16]3)[CH2:18][CH2:19]2)(=[O:34])=[O:35])[CH:32]=1

Participants

3

Procedure

The title compound is prepared analogously as described for GP1 using 5-(3,4-dimethoxyphenyl)-4,4-dimethyl-2-(piperidin-4-yl)-2,4-dihydro-3H-pyrazol-3-one (compound B1) and 5-chloro-2-methoxybenzenesulfonyl chloride as starting compounds. The crude product is purified by crystallization from EA and diethyl ether to yield the title compound.

Workup

  1. customThe title compound is prepared analogously
  2. customThe crude product is purified by crystallization from EA and diethyl ether

Sources & evidence

ORD record
ord-a88760ab995c4adbb1220f265d2e9e15
Source dataset
uspto-grants-2016_05
Patent number
US09340522B2

Reaction notes

Loading…